Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) Equity Average (2016 - 2025)

Historic Equity Average for Prestige Consumer Healthcare (PBH) over the last 15 years, with Q4 2025 value amounting to $1.8 billion.

  • Prestige Consumer Healthcare's Equity Average rose 381.3% to $1.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.8 billion, marking a year-over-year increase of 381.3%. This contributed to the annual value of $1.7 billion for FY2025, which is 1250.14% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Equity Average of $1.8 billion as of Q4 2025, which was up 381.3% from $1.8 billion recorded in Q3 2025.
  • Prestige Consumer Healthcare's Equity Average's 5-year high stood at $1.8 billion during Q2 2025, with a 5-year trough of $1.3 billion in Q1 2021.
  • Over the past 5 years, Prestige Consumer Healthcare's median Equity Average value was $1.6 billion (recorded in 2022), while the average stood at $1.6 billion.
  • In the last 5 years, Prestige Consumer Healthcare's Equity Average skyrocketed by 1570.32% in 2021 and then plummeted by 743.04% in 2023.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Equity Average stood at $1.5 billion in 2021, then increased by 10.96% to $1.7 billion in 2022, then fell by 5.15% to $1.6 billion in 2023, then increased by 12.23% to $1.8 billion in 2024, then increased by 3.81% to $1.8 billion in 2025.
  • Its last three reported values are $1.8 billion in Q4 2025, $1.8 billion for Q3 2025, and $1.8 billion during Q2 2025.